Claudia Balotta

Claudia Balotta publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Claudia Balotta sits on this spectrum.

Claudia Balotta D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Claudia Balotta sits on this spectrum.

Overview

Best Publications

• Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC

  Alessia Lai;Francesco Roberto Simonetti;Gaetano Brindicci;Annalisa Bergna

  667
  Citations

• Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

  Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  568
  Citations

• Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

  P. Lusso;F. Cocchi;C. Balotta;P. D. Markham

  393
  Citations

• Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe

  Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert

  305
  Citations

• Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

  Miriam Lichtner;Paola Cicconi;Serena Vita;Alessandro Cozzi-Lepri

  227
  Citations

• Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection.

  d'Arminio Monforte A;Testa L;Adorni F;Chiesa E

  197
  Citations

• Homozygous Δ32 deletion of the Ccr-5 chemokine receptor gene in an Hiv-1-infected patient

  Claudia Balotta;Patrizia Bagnarelli;Michela Violin;Anna Lisa Ridolfo

  194
  Citations

• Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

  L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev

  187
  Citations

• HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

  Ana B. Abecasis;Annemarie M.J. Wensing;Dimitris Paraskevis;Jurgen Vercauteren;Jurgen Vercauteren

  186
  Citations

• Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3.

  P Lusso;M Malnati;A De Maria;C Balotta

  177
  Citations

• Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

  Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  174
  Citations

• Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages.

  C Balotta;P Lusso;R Crowley;R C Gallo

  162
  Citations

• Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

  Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  159
  Citations

• Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.

  Michela Violin;Alessandro Cozzi-Lepri;Rossella Velleca;Antonella Vincenti

  148
  Citations

• The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.

  Pillay D;Bhaskaran K;Jurriaans S;Prins M

  142
  Citations

• Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor.

  Alberto Mantovani;Wang Ji Ming;Claudia Balotta;Benomar Abdeljalil

  142
  Citations

• The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

  David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  141
  Citations

• Type 1 Cytokine Production and Low Prevalence of Viral Isolation Correlate with Long-Term Nonprogression in HIV Infection

  Mario Clerici;Claudia Balotta;Luca Meroni;Enrica Ferrario

  139
  Citations

• Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy.

  Gianguglielmo Zehender;Alessia Lai;Annalisa Bergna;Luca Meroni

  138
  Citations

• Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

  S. Rusconi;S. La Seta Catamancio;P. Citterio;S. Kurtagic

  134
  Citations

• Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.

  Patrizia Bagnarelli;Anna Valenza;Stefano Menzo;Riccardo Sampaolesi

  120
  Citations

• Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug-Naive Patients Treated with Protease Inhibitor-Based Therapy

  Carlo F. Perno;Alessandro Cozzi-Lepri;Claudia Balotta;Federica Forbici

  120
  Citations

• Neurological Symptoms during Primary Human Immunodeficiency Virus (HIV) Infection Correlate with High Levels of HIV RNA in Cerebrospinal Fluid

  G. Tambussi;A. Gori;B. Capiluppi;C. Balotta

  117
  Citations

• Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

  Bernard Masquelier;Krishnan Bhaskaran;Deenan Pillay;Robert Gifford

  111
  Citations